Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Find out which travel credit cards without fees provide the most rewarding experiences for your travels.
26,586 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
AI-driven capital spending is set to surge, pushing capex crosses trillion next. Here are two industrial stocks—Verti...
When a company earns a spot in the Nasdaq-100, investors watch for clues about future moves. This article digs into t...
Hungary blocks a massive EU loan to Ukraine, tying funding to the restart of Druzhba pipeline oil flows after a disru...
Bitcoin sits around $66,800 as the BITO ETF regains attention amid competition from cheaper spot BTC products. Invest...
Oil jumps to its highest price since 2023 as a hot U.S. jobs report spurs inflation worries, sending stocks lower and...
As AI momentum pauses, three AI-driven tech stocks worth buying the dip emerge with signs of improving fundamentals a...
A Trump-era regulatory push aims to bring major crypto firms into the federal banking system, signaling a potential o...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Bitcoin climbs past $80,000 on renewed ETF demand and institutional buying. Analysts map potential paths for BTC and ...
Fridays bring a fresh round of analyst calls that moved key names across tech and consumer staples. Investors weigh n...
Researchers report clues that AI seems turn marxist after heavy workloads, raising questions for workers and investor...